story of the week
Cabazitaxel as Second-Line in Patients With HER2– Metastatic Breast Cancer Previously Treated With Taxanes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 2 Study of Cabazitaxel as Second-Line Treatment in Patients With HER2-Negative Metastatic Breast Cancer Previously Treated With Taxanes—A Hellenic Cooperative Oncology Group (HeCOG) Trial
Br. J. Cancer 2020 Aug 01;123(3)355-361, A Koutras, F Zagouri, GA Koliou, E Psoma, I Chryssogonidis, G Lazaridis, D Tryfonopoulos, A Kotsakis, E Res, NK Kentepozidis, E Razis, A Psyrri, G Koumakis, HP Kalofonos, MA Dimopoulos, G FountzilasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.